Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:51 AM
Ignite Modification Date:
2025-12-24 @ 11:51 AM
NCT ID:
NCT00773461
Eligibility Criteria:
Inclusion Criteria:
* adult patients, 18-70 years of age;
* rheumatoid arthritis for \>= 6 months;
* receiving permitted DMARDs, at a stable dose, for \>= 8 weeks prior to baseline;
* current inadequate clinical response to DMARDs.
Exclusion Criteria:
* major surgery, including joint surgery, within 8 weeks before entering study, or planned major surgery within 6 months following randomization;
* rheumatic autoimmune disease or inflammatory joint disease other than rheumatoid arthritis;
* unsuccessful treatment with an anti-TNF agent;
* previous treatment with tocilizumab.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
70 Years
Study:
NCT00773461
Study Brief:
Protocol Section:
NCT00773461